|
194 |
Here is the thing. The Socius deal has been |
tangerine |
11/15/2012 6:57:03 PM |
|
193 |
No doubt I don't get upset about the day to day |
ryan g |
11/15/2012 6:52:19 PM |
|
192 |
I am becoming immune to the BS. This CC was great |
tangerine |
11/15/2012 6:44:10 PM |
|
191 |
It all seems very coordinated to me. A good CC |
ryan g |
11/15/2012 6:25:28 PM |
|
190 |
And that is exactly why I picked up shares |
Couch |
11/15/2012 5:29:38 PM |
|
189 |
Conference call was great which is why you had |
tangerine |
11/15/2012 5:25:56 PM |
|
188 |
This stock certainly puts one up against oneself |
Couch |
11/15/2012 5:02:29 PM |
|
187 |
Exactly. The more leverage and options we have, |
ryan g |
11/15/2012 3:44:34 PM |
|
186 |
I noticed that too since I keep my spreadsheet |
tangerine |
11/15/2012 3:39:33 PM |
|
184 |
Just noticed something.. if you look at the 10-Q |
AJM16w |
11/15/2012 3:35:23 PM |
|
183 |
Well, they have options which is always a good |
g2 |
11/15/2012 2:39:21 PM |
|
182 |
I love how we are playing our cards regarding |
ryan g |
11/15/2012 1:54:55 PM |
|
178 |
3.3m is the IMS number but that does not include |
tangerine |
11/15/2012 1:18:34 PM |
|
177 |
I am bummed I couldn't listen in this AM but will |
Hike |
11/15/2012 12:53:24 PM |
|
176 |
Its the same API as the 37.5mg. So if they |
tangerine |
11/15/2012 11:59:50 AM |
|
175 |
Yep, seemed to me they think it is in the short |
g2 |
11/15/2012 11:52:45 AM |
|
174 |
Immediate catalysts Naltrexone Launch |
tangerine |
11/15/2012 11:51:11 AM |
|
173 |
Agreed, should begin to move |
g2 |
11/15/2012 11:47:37 AM |
|
172 |
I think we are pretty sure what MIK001 is, I am |
steges |
11/15/2012 11:44:40 AM |
|
171 |
I thought it was great. When you this void |
tangerine |
11/15/2012 11:42:17 AM |
|
169 |
I thought the Cc was pretty informative overall. |
g2 |
11/15/2012 11:36:56 AM |
|
167 |
On the call, Jerry noted that the IMS data does |
tangerine |
11/15/2012 11:27:54 AM |
|
166 |
Phendimetrazine revenue IMS #s don't include the |
NASDAQ2020 |
11/15/2012 11:24:13 AM |
|
165 |
yes. Naltrexone is the next one to be approved |
tangerine |
11/15/2012 11:23:30 AM |
|
164 |
Watson can afford to wait it out right now. I |
tangerine |
11/15/2012 11:23:01 AM |
|
163 |
Did I hear that right, Elite is awaiting the |
AJM16w |
11/15/2012 11:22:36 AM |
|
162 |
I agree, but they are essentially in an arms race |
steges |
11/15/2012 11:14:02 AM |
|
161 |
Like Jerry said in an earlier CC, the value of |
tangerine |
11/15/2012 11:11:20 AM |
|
160 |
Yes, things looking good. Gonna take awhile but |
steges |
11/15/2012 11:09:52 AM |
|
159 |
Depends f what your plan is plus you don't know |
tangerine |
11/15/2012 11:08:26 AM |
|
157 |
API issue sounds like it is about to be resolved |
tangerine |
11/15/2012 11:06:17 AM |
|
156 |
Novel should cover it all. That would be |
steges |
11/15/2012 11:03:01 AM |
|
155 |
They like the Socius deal because they can draw |
tangerine |
11/15/2012 11:01:51 AM |
|
154 |
Good call. Socius deal available, same economics |
tangerine |
11/15/2012 11:00:36 AM |
|
153 |
Hard to tell. They need to really move it on the |
steges |
11/15/2012 10:59:54 AM |
|
152 |
Are BE studies on track any before en of |
NASDAQ2020 |
11/15/2012 10:42:53 AM |
|
150 |
Im on hold 10 mins?? has it |
NASDAQ2020 |
11/15/2012 10:01:19 AM |
|
149 |
One would think Naltrexone will be right around |
ryan g |
11/15/2012 9:50:32 AM |
|
148 |
Interesting, nice publicity |
g2 |
11/15/2012 9:24:04 AM |
|
147 |
Something else to think about regarding |
tangerine |
11/15/2012 8:38:37 AM |
|
146 |
Of course it is.... 30 million dollar |
tangerine |
11/15/2012 7:40:58 AM |
|
145 |
That helps. Interestingly this was listed as |
Hike |
11/15/2012 7:34:12 AM |
